Cytosaminomycin A
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Category | Antibiotics |
Catalog number | BBF-01140 |
CAS | 157878-02-9 |
Molecular Weight | 514.59 |
Molecular Formula | C22H34N4O8S |
Online Inquiry
Description
It is produced by the strain of Streptomyces sp. KO-8119. It has anti-eimeria Tenella activity. The concentration of Cytosaminomycin A without cleavage in chicken embryo cells is 0.3-0.6 μg/mL.
Specification
Synonyms | N-[3-(Methylthio)acryloyl]-1-[4-O-[4-(dimethylamino)-4,6-dideoxy-alpha-D-glucopyranosyl]-2,6-dideoxy-beta-D-arabino-hexopyranosyl]cytosine |
IUPAC Name | (E)-N-[1-[(2R,4R,5S,6R)-5-[(2R,3R,4S,5S,6R)-5-(dimethylamino)-3,4-dihydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]-2-oxopyrimidin-4-yl]-3-methylsulfanylprop-2-enamide |
Canonical SMILES | CC1C(C(C(C(O1)OC2C(OC(CC2O)N3C=CC(=NC3=O)NC(=O)C=CSC)C)O)O)N(C)C |
InChI | InChI=1S/C22H34N4O8S/c1-11-17(25(3)4)18(29)19(30)21(33-11)34-20-12(2)32-16(10-13(20)27)26-8-6-14(24-22(26)31)23-15(28)7-9-35-5/h6-9,11-13,16-21,27,29-30H,10H2,1-5H3,(H,23,24,28,31)/b9-7+/t11-,12-,13-,16-,17-,18+,19-,20-,21-/m1/s1 |
InChI Key | OEIFFRHFKRNPAL-ZQEFWBPISA-N |
Properties
Appearance | Pale Yellow Powder |
Density | 1.47 g/cm3 |
Solubility | Soluble in Methanol |
Reference Reading
1. Cytosaminomycins, new anticoccidial agents produced by Streptomyces sp. KO-8119. I. Taxonomy, production, isolation and physico-chemical and biological properties
K Haneda, M Shinose, A Seino, N Tabata, H Tomoda, Y Iwai, S Omura J Antibiot (Tokyo). 1994 Jul;47(7):774-81. doi: 10.7164/antibiotics.47.774.
Streptomyces amakusaensis KO-8119, a soil isolate, was found to produce a series of new anticoccidial compounds. Four active compounds, designated as cytosaminomycins A, B, C and D, were isolated from the fermentation broth of the producing strain by solvent extraction, silica gel column chromatography and preparative HPLC. Cytosaminomycins inhibited the growth of Eimeria tenella in an in vitro assay system using primary chicken embryonic cells as a host. No schizont in the cells was observed at concentrations ranging from 0.3 to 0.6 microgram/ml for cytosaminomycins A, B and C, and at 2.5 micrograms/ml for cytosaminomycin D.
2. Synthetic study of cytosaminomycins using the intramolecular glycosylation as a key step
Hideyuki Sugimura Nucleic Acids Res Suppl. 2003;(3):21-2. doi: 10.1093/nass/3.1.21.
2',6'-Dideoxy-beta-D-hexopyranosyl pyrimidine nucleoside, which is a component of anticoccidal antibiotics--cytosaminomycins, was synthesized in a stereoselective manner via the intramolecular pyrimidine delivery method. Further glycosylaion of the 4'-position with a glycosyl fluoride gave the disaccharide nucleoside skeleton of the cytosaminomycins.
3. Cytosaminomycins, new anticoccidial agents produced by Streptomyces sp. KO-8119. II. Structure elucidation of cytosaminomycins A, B, C and D
K Shiomi, K Haneda, H Tomoda, Y Iwai, S Omura J Antibiot (Tokyo). 1994 Jul;47(7):782-6. doi: 10.7164/antibiotics.47.782.
Structures of novel anticoccidial antibiotics, cytosaminomycins A, B, C and D, were elucidated by NMR studies. Cytosaminomycins were shown to be nucleoside antibiotics related to oxyplicacetin. Their carboxylic acid moieties bonded to the cytosine residue were different from that of oxyplicacetin. The carboxylic acids contained in cytosaminomycins A, B, C and D were (E)-3-(methylthio)acrylic acid, 4-methylaminobenzoic acid, 3-methylcrotonic acid, and tiglic acid, respectively.
Recommended Products
BBF-05817 | Astaxanthin | Inquiry |
BBF-01732 | Mevastatin | Inquiry |
BBF-05880 | N-Me-L-Ala-maytansinol | Inquiry |
BBF-02594 | Pyrrolnitrin | Inquiry |
BBF-03800 | Moxidectin | Inquiry |
BBF-03428 | Tubermycin B | Inquiry |
Bio Calculators
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
* Total Molecular Weight:
g/mol
Tip: Chemical formula is case sensitive. C22H30N4O √ c22h30n40 ╳